Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
Reolid A, Armesto S, Sahuquillo-Torralba A, Torres T, Feltes R, Vilarrasa E, Belinchón I, Cueva P, Rodríguez L, Romero-Maté A, Vidal D, Coto-Segura P, Herrera-Acosta E, Riera-Monroig J, Salgado L, Llamas-Velasco M, Daudén E. Reolid A, et al. Among authors: feltes r. J Am Acad Dermatol. 2022 Sep;87(3):705-709. doi: 10.1016/j.jaad.2022.05.047. Epub 2022 May 28. J Am Acad Dermatol. 2022. PMID: 35640798 Free article. No abstract available.
Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice.
Reymundo A, Vilarrasa E, Baniandrés O, Rodríguez-Fernández-Freire L, Feltes R, Llamas-Velasco M, Daudén E. Reymundo A, et al. Among authors: feltes r. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e849-e851. doi: 10.1111/jdv.18317. Epub 2022 Jun 24. J Eur Acad Dermatol Venereol. 2022. PMID: 35689497 No abstract available.
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting.
Martos-Cabrera L, Llamas-Velasco M, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera-Diaz R, de la Cueva P, Martorell-Calatayud A, Ballescá F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado-Boquete L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés O, Feltes R, Alsina M, Daudén E. Martos-Cabrera L, et al. Among authors: feltes r. Int J Dermatol. 2023 Mar;62(3):e146-e149. doi: 10.1111/ijd.16365. Epub 2022 Jul 22. Int J Dermatol. 2023. PMID: 35867958 No abstract available.
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
Chicharro P, Llamas-Velasco M, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera R, De la Cueva P, Martorell-Calatayud A, Ballescà F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés-Rodríguez O, Feltes R, Alsina M, Daudén E. Chicharro P, et al. Among authors: feltes r. Dermatol Ther. 2022 Aug;35(8):e15653. doi: 10.1111/dth.15653. Epub 2022 Jun 29. Dermatol Ther. 2022. PMID: 35731640
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain.
Daudén E, de Lima GPG, Armesto S, Herrera-Acosta E, Vidal D, Villarasa E, Rivera R, de la Cueva P, Martorell A, Ballesca F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés O, Feltes R, Alsina M, Llamas-Velasco M. Daudén E, et al. Among authors: feltes r. Dermatol Ther (Heidelb). 2021 Dec;11(6):2207-2215. doi: 10.1007/s13555-021-00606-9. Epub 2021 Sep 24. Dermatol Ther (Heidelb). 2021. PMID: 34561788 Free PMC article.
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.
Chicharro P, Llamas-Velasco M, Armesto S, Herrera Acosta E, Vidal D, Vilarrasa E, Rivera-Diaz R, De-la-Cueva P, Martorell-Calatayud A, Ballescà F, Belinchon I, Carretero G, Rodriguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés Rodríguez O, Feltes R, Riera-Monroig J, Dauden E. Chicharro P, et al. Among authors: feltes r. Dermatol Ther. 2022 Dec;35(12):e15929. doi: 10.1111/dth.15929. Epub 2022 Oct 19. Dermatol Ther. 2022. PMID: 36223184
Recalcitrant palmoplantar pustular psoriasis treated with etanercept.
Floristan U, Feltes R, Ramírez P, Alonso ML, De Lucas R. Floristan U, et al. Among authors: feltes r. Pediatr Dermatol. 2011 May-Jun;28(3):349-50. doi: 10.1111/j.1525-1470.2011.01234.x. Epub 2011 Mar 3. Pediatr Dermatol. 2011. PMID: 21371112
Diffuse melanosis and ascites due to metastatic malignant melanoma.
Sendagorta E, Pizarro A, Feito M, Mayor M, Ramírez P, Floristan U, Feltes R. Sendagorta E, et al. Among authors: feltes r. ScientificWorldJournal. 2008 May 23;8:556-7. doi: 10.1100/tsw.2008.78. ScientificWorldJournal. 2008. PMID: 18516477 Free PMC article.
34 results